Twins' Health Deteriorates After Switch to Russian Generic Drug

If they start mass purchasing another drug after this, the question will arise what to do with the already...

Consensus

The twins Ira and Polina Potekhina from Chelyabinsk were switched from original Spinraza to a domestic generic drug after five years of successful treatment.
After the switch, the twins experienced fever, severe pain, and a significant regression in motor functions.
The mother refused to continue the injections due to their danger to her daughters.
A polyclinic filed a lawsuit seeking permission for forced intervention.
A protest attempt on Red Square ended in detention.
Hundreds of children with spinal muscular atrophy in Russia have been switched to the domestic generic drug.
The manufacturer claims there are no new risks associated with the generic drug.
Parents report disease progression after the switch.
Medical commissions issue conflicting conclusions.
Government officials save billions through state procurement.
The issue centers on the interchangeability of the original and generic drugs.